SAN FRANCISCO & PALO ALTO, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc., an innovator in treatment solutions for ear, nose and throat clinicians and patients, today reported data from its pivotal ...

On May 13, 2022, Medtronic, Inc. announced that it completed the acquisition of Intersect ENT, Inc. The transaction was only able to gain approval of the Federal Trade Commission (FTC) upon the ...

The acquisition will allow Intersect ENT’s portfolio to support routine and complex procedures and positions the company to serve the growing market for ENT services, the statement said. It will also ...

Staying true to its pledge to crack down on potentially anticompetitive megamergers in the healthcare industry, the U.S. Federal Trade Commission has ordered Medtronic and Intersect ENT to adjust the ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT ®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced the U ...

Intersect ENT XENT reported first-quarter 2022 GAAP loss per share of 85 cents, wider than the year-ago adjusted loss of 61 cents. The figure was also wider than the year-ago adjusted loss of 34 cents ...

Intersect ENT has announced it has received FDA approval of the company’s second steroid-releasing product, according to a news release (pdf). The PROPEL mini is designed for localized drug delivery ...

Medtronic closed on its $1.1 billion acquisition of Intersect ENT. The closing comes a few days after the Federal Trade Commission ordered the Dublin-based company to divest Intersect's Fiagon ...

DUBLIN and MENLO PARK, Calif., May 13, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it has completed the acquisition of Intersect ENT, ...

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money managers and analyze ...

Acquisition adds innovative bioabsorbable steroid-eluting sinus implants to ENT portfolio DUBLIN and MENLO PARK, Calif., May 13, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in ...